Trial Profile
A Prospective, Double-masked, Placebo Controlled Comparison of Topical 0.15% Gancyclovir Gel (Zirgan) Versus 0.3% Hypromellose Gel (Genteal Gel; Placebo) for the Treatment of Herpes Zoster Keratitis
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 13 Jul 2021
Price :
$35
*
At a glance
- Drugs Ganciclovir (Primary) ; Hypromellose
- Indications Ocular herpes simplex
- Focus Therapeutic Use
- 06 Dec 2020 Status changed from recruiting to discontinued.
- 11 Mar 2019 Planned End Date changed from 1 Jan 2019 to 1 Dec 2020.
- 11 Mar 2019 Planned primary completion date changed from 1 Jan 2018 to 1 Dec 2019.